Evidence map›Paper›PMID 33392939›Full record

ArticleInternational ophthalmology2021

Vision outcomes with a new monofocal IOL.

Esat Cinar, Hülya Bolu, Gökhan Erbakan, Berna Yuce, Fatih Aslan, Murat Fece, Sinan Emre

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Clinical outcomes with an aspheric monofocal and a new enhanced monofocal intraocular lens with modified optical profile.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Trial
  4. Trial
  5. Adaptive-Optics-Based Simulation of Astigmatism Effects on Visual Acuity with Enhanced Monofocal Intraocular Lenses.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Intermediate Vision Following Monofocal IOL Implantation.Clinical ophthalmology (Auckland, N.Z.) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Real world outcomes of the new Tecnis Eyhance IOL.European journal of ophthalmology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esat CinarEkol Eye Hospital, Izmir, Turkey. esatcinar@yahoo.com.ORCID http://orcid.org/0000-0002-8257-6884
Hülya BoluEkol Eye Hospital, Izmir, Turkey.
Gökhan ErbakanEkol Eye Hospital, Izmir, Turkey.
Berna YuceEkol Eye Hospital, Izmir, Turkey.
Fatih AslanEkol Eye Hospital, Izmir, Turkey.
Murat FeceEkol Eye Hospital, Izmir, Turkey.
Sinan EmreEkol Eye Hospital, Izmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to compare the distance, intermediate, and near visual performance of a new IOL (ICB00, Eyhance, Tecnis) and classic monofocal IOL (SN60WF IQ AcrySof, Alcon) after unilateral implantation.

methodsSixty-three patients were unilaterally implanted with the ICB00 Eyhance IOL (study group) and 65 patients with the SN60WF IQ AcrySof (control group). Visual performance was assessed with monocular corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA) at 4 m, corrected intermediate visual acuity (CIVA) and uncorrected intermediate visual acuity (UIVA) at 60 cm, and corrected near visual acuity (CNVA) and uncorrected near visual acuity (UNVA) at 40 cm.

resultsCDVA, UDVA, CNVA, and UNVA values did not differ significantly between the study and control groups (0.02 ± 0.02 vs. 0.03 ± 0.02, p = 0.523; 0.05 ± 0.13 vs. 0.05 ± 0.15, p = 0.637; 0.46 ± 0.17 vs. 0.46 ± 0.15, p = 0.821; and 0.47 ± 0.21 vs. 0.49 ± 0.25, p = 0.612; respectively), whereas the study group showed significantly better results for CIVA (0.28 ± 0.12 vs. 0.38 ± 0.13, p = 0.001) and UIVA (0.31 ± 0.16 vs. 0.41 ± 0.12, p = 0.001).

conclusionsThe Eyhance IOL, which features a new optical design based on a continuous power profile, was determined to be superior to a classic monofocal IOL for intermediate visual acuity and not inferior for corrected and uncorrected distance and near visual acuity.

Indexed as

Lenses, IntraocularPhacoemulsificationContrast SensitivityHumansLens Implantation, IntraocularPatient SatisfactionProspective StudiesProsthesis DesignCataract surgeryIntermediate visual acuityMonofocal lenses

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.